Mt. Donato et al., NITRIC OXIDE-MEDIATED INHIBITION OF CYTOCHROME-P450 BY INTERFERON-GAMMA IN HUMAN HEPATOCYTES, The Journal of pharmacology and experimental therapeutics, 281(1), 1997, pp. 484-490
The role of nitric oxide in the inhibition of the cytochrome P450 syst
em produced by interferon-gamma in human hepatocytes has been examined
. Nitric oxide exogenously released from S-nitroso-N-acetylpenicillami
ne produced a dose-dependent decrease in cytochrome P4501A2 activity,
assessed as 7-ethoxy resorufin O-deethylation. After 24 hr of treatmen
t with 300 U/ml interferon-gamma, a rise in nitric oxide release (200%
over control cells) and a parallel inhibition in 7-ethoxyresorufin O-
deethylase activity (50% of control) were observed in human hepatocyte
s. This inhibition was concentration-dependently prevented by N-G-mono
methyl-L-arginine, a competitive inhibitor of nitric oxide biosynthesi
s. Comparable results were observed for cytochrome P4502A6 (7-coumarin
hydroxylation), 2B6 (7-benzoxyresorufin O-dealkylation) and 3A4 (test
osterone 6 beta-hydroxylation) activities. Decreases in CYP1A2 activit
y found after exposure of 3-methylcholanthrene-treated hepatocytes to
interferon-gamma were also reversed in the presence of N-G-monomethyl-
L-arginine. Down-regulation of cytochrome P4501A2 and 3A4 expression b
y interferon-gamma was observed in parallel. This study suggests that
at least some of the interferon-gamma effects on human hepatocyte cyto
chrome P450 isoenzymes are mediated by nitric oxide biosynthesis.